Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 12, 2004
Finance

Ebb & Flow

BioCentury | May 24, 2004
Clinical News

Humira adalimumab autoimmune data

BioCentury | May 24, 2004
Clinical News

Humira adalimumab: Phase III data

BioCentury | Feb 2, 2004
Clinical News

Humira adalimumab: Phase III data; marketed

BioCentury | Nov 3, 2003
Clinical News

Humira adalimumab: Marketed

BioCentury | Oct 6, 2003
Finance

3Q approvals

Items per page:
1 - 10 of 90